Skip to menu Skip to content Skip to footer

2024

Conference Publication

004 Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitors

Ailabouni, Nagham J, Thompson, Wade, Hilmer, Sarah N, Lyntara, Q, Uirke Janet, M, Bourke, Qcneece Alice, Furst, Chloe and Reeve, Emily (2024). 004 Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitors. BMJ Publishing Group Ltd. doi: 10.1136/bmjebm-2024-sdc.4

004 Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitors

2024

Conference Publication

244 Deprescribing and shared decision-making research

Scott, Sion, Weir, Kristie Rebecca, Denig, Petra, Ailabouni, Nagham and López-Toribio, María (2024). 244 Deprescribing and shared decision-making research. BMJ Publishing Group Ltd. doi: 10.1136/bmjebm-2024-sdc.243

244 Deprescribing and shared decision-making research

2023

Conference Publication

Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations

Shafiee Hanjani, Leila, Weir, Kristie, Reeve, Emily, Brandt, Nicole, Tao, Eric and Ailabouni, Nagham J. (2023). Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023.

Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations

2023

Conference Publication

An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?

Elsedfy, Youmna, Mangin, Dee, Jamieson, Hamish, Bergler, Ulrich, Nishtala, Prasad, Weaver, Susan K., Reeve, Emily, Freeman, Christopher R. and Ailabouni, Nagham (2023). An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023.

An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?

2023

Conference Publication

Top 10 unanswered questions about quality use of medicines in people living with dementia

Tan, Edwin, Reeve, Emily, Ailabouni, Nagham, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Ellett, Lisa Kalisch, Gilmartin-Thomas, Julia, Sluggett, Janet, Quirke, Lyntara and Hilmer, Sarah (2023). Top 10 unanswered questions about quality use of medicines in people living with dementia. International Social Pharmacy Workshop 2022, Sydney, NSW Australia, 11-14 July 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.sapharm.2023.04.035

Top 10 unanswered questions about quality use of medicines in people living with dementia

2023

Conference Publication

Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study

Ming, Jiun, Reeve, Emily, Chai, Wern Chern, Ailabouni, Nagham, Proudman, Susanna and Wiese, Michael (2023). Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057

Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study

2023

Conference Publication

Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis

Maher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2023). Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057

Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis

2022

Conference Publication

Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis

Maher, Dorsa, Reeve, Emily, Tan, Jiun Ming, Tantiongco, Mahsa M., Ailabouni, Nagham J., Hopkins, Ashley M., Woodman, Richard J., Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael D. (2022). Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis. APSA-ASCEPT, Perth, WA, Australia, 29 November - 2 December 2022.

Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis

2022

Conference Publication

Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia

Ailabouni, Nagham J., Weir, Kristie, Maher, Dorsa, Hilmer, Sarah, Koeper, Ivanka, Russell, Patrick, Shakib, Sepehr and Reeve, Emily (2022). Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia. APSA-ASCEPT, Perth, WA Australia, 29 November - 2 December 2022.

Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia

2022

Conference Publication

Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing

Murray, Lauren, Reeve, Emily, Ailabouni, Nagham, Kalisch Ellett, Lisa and Weise, Michael (2022). Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing. The Pharmaceutical Society of Australia, Sydney, Australia, 29-31 July 2022.

Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing